FindTrial
Sign In

MicroRNAs involve in the Act1/IL-17RA mediation mechanism in cerebral ischemia reperfusion

BMSCs involve in the IL-17/Act1 mediation mechanism in cerebral ischemia reperfusion

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RNC-17011481
Enrollment
Unknown
Registered
2017-05-24
Start date
2017-05-24
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Case series:Nil

Sponsors

First Affiliated Hospital, Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All the patients were diagnosed under the diagnosis guideline of acute ischemic stroke of China; 2. All the cases were proved to be the first time to get ischemic stroke through the Computed Tomography (CT) scan and Magnetic Resonance Imaging (MRI) of brain; 3. All the cases received intravenous thrombolysis in 6 hours after symptoms appeared.

Exclusion criteria

Exclusion criteria: 1. Patients with tumors, myocardial infarction, and serious diseases of liver, lung and kidney; 2. Patients under chemo-radiotherapy or using immunosuppressor; 3. Patients with acute or chronic infection, and patients underwent surgery or wounded recently.

Design outcomes

Primary

MeasureTime frame
IL-17;miR-215;—

Countries

China

Contacts

Public ContactLi Guozhong

First Affiliated Hospital, Harbin Medical University

lgzhrbmu1962@163.com+86 0451-85555886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026